TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,000 | +66.7% | 38,000 | +111.1% | 0.00% | – |
Q2 2022 | $18,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
Q4 2021 | $18,000 | +20.0% | 18,000 | +20.0% | 0.00% | – |
Q3 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q3 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | +7.1% | 15,000 | 0.0% | 0.00% | – |
Q3 2019 | $14,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2019 | $14,000 | -6.7% | 15,000 | 0.0% | 0.00% | – |
Q1 2019 | $15,000 | +7.1% | 15,000 | 0.0% | 0.00% | – |
Q4 2018 | $14,000 | -6.7% | 15,000 | 0.0% | 0.00% | – |
Q3 2018 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2018 | $15,000 | -16.7% | 15,000 | -21.1% | 0.00% | – |
Q1 2018 | $18,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2017 | $18,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q3 2017 | $18,000 | -5.3% | 19,000 | 0.0% | 0.00% | – |
Q2 2017 | $19,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2017 | $19,000 | -5.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2016 | $20,000 | -13.0% | 19,000 | 0.0% | 0.00% | – |
Q3 2016 | $23,000 | -8.0% | 19,000 | 0.0% | 0.00% | – |
Q2 2016 | $25,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2016 | $25,000 | -39.0% | 19,000 | -26.9% | 0.00% | – |
Q4 2015 | $41,000 | +64.0% | 26,000 | +36.8% | 0.00% | – |
Q3 2015 | $25,000 | -7.4% | 19,000 | 0.0% | 0.00% | – |
Q2 2015 | $27,000 | -3.6% | 19,000 | 0.0% | 0.00% | – |
Q1 2015 | $28,000 | +7.7% | 19,000 | 0.0% | 0.00% | – |
Q4 2014 | $26,000 | +8.3% | 19,000 | 0.0% | 0.00% | – |
Q3 2014 | $24,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q2 2014 | $24,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2014 | $24,000 | -36.8% | 19,000 | -47.2% | 0.00% | -100.0% |
Q4 2013 | $38,000 | +90.0% | 36,000 | +89.5% | 0.00% | 0.0% |
Q3 2013 | $20,000 | 0.0% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $20,000 | – | 19,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |